Eric M. Chang, M.D. is an assistant professor in the Department of Radiation Medicine. Dr. Chang’s clinical work focuses on the use of palliative radiation therapy for patients with advanced cancer in both the inpatient and outpatient settings. He received his medical degree from the University of California, San Francisco and completed his residency training at the University of California, Los Angeles. His research interests include optimizing the delivery of palliative radiation therapy in effort to improve patient outcomes and minimize treatment burden. As a former healthcare consultant, Dr. Chang also has particular interest in economic analysis and health policy, with special focus on decision modeling and health state valuation.
- Assessing the cost and cost-effectiveness of multiple treatment modalities in the palliation of bone and spine metastases
- Estimating utility weights and patient preferences for cancer-related health states
- Improving education in primary palliative care skills for radiation oncology residents
Chang EM. The Week After Your Death. Journal of General Internal Medicine. March 31, 2019. https://www.sgim.org/web-only/medical-humanities/the-week-after-your-death#
Chang EM, Shaverdian N, Capiro N, Steinberg ML, Raldow AC. Cost-effectiveness of external beam radiation therapy versus percutaneous image-guided cryoablation for palliation of uncomplicated bone metastases. J Vasc Interv Radiol. 2020;31(8):1221-1232. doi: 10.1016/j.jvir.2020.03.027.
Parikh NR, Chang EM, Nickols NG, Rettig MB, Raldow AC, King CR, Steinberg ML, Koontz BF, Vapiwala N, Deville C, Feng FY, Spratt DE, Reiter RE, Phillips R, Ost P, Tran PT, Kishan AU. Cost-effectiveness of metastasis-directed therapy in oligorecurrent hormone-sensitive prostate cancer. Int J Radiat Oncol Biol Phys. 2020;S0360-3016(20)31250-5. doi: 10.1016/j.ijrobp.2020.06.009.
Parikh NR, Kundu PK, Levin-Epstein R, Chang EM, Hegde JV, Tenn S, Agazaryan N, Steinberg ML, Kaprealian TK. Time-driven activity based costing comparison of stereotactic radiosurgery to multiple brain lesions utilizing single-isocenter vs. multiple-isocenter technique. Int J Radiat Oncol Biol Phys. 2020;S0360-3016(20)31322-5. doi: 10.1016/j.ijrobp.2020.06.035.
Parikh NR, Chang EM, Kishan AU, Steinberg ML, Raldow AC. Time-driven activity-based cost
analysis of telemedicine services in radiation oncology. Int J Radiat Oncol Biol Phys. 2020; 108(2): 430-4. doi: 10.1016/j.ijrobp.2020.06.053.
Chang EM, Falit BP, Raldow AC. Evaluating a utilization management policy in radiation oncology. JAMA Oncol. April 2020. doi:10.1001/jamaoncol.2020.0447
Huang TQ, Chang EM, Grogan TR, Martin EJ, Raldow AC. Opioid prescription patterns among radiation oncologists in the United States. Cancer Med. March 2020. doi:10.1002/cam4.2907
Chang EM, Saigal CS, Raldow AC. Explaining health state utility assessment. JAMA. February 2020. doi:10.1001/jama.2020.0656
Shaverdian N, Chang EM, Chu F-I, et al. Impact of open access to physician notes on radiation oncology patients: results from an exploratory survey. Pract Radiat Oncol. 2019;9(2):102-107. doi:10.1016/j.prro.2018.10.004
Chang EM, Gillespie EF, Shaverdian N. Truthfulness in patient-reported outcomes: factors affecting patients’ responses and impact on data quality. Patient Relat Outcome Meas. 2019;10:171-186. doi:10.2147/PROM.S178344
Chang EM, Punglia RS, Steinberg ML, Raldow AC. Cost effectiveness of the Oncotype DX Genomic Prostate Score for guiding treatment decisions in patients with early stage prostate cancer. Urology. 2019;126:89-95. doi:10.1016/j.urology.2018.12.016
Raldow AC, Chang EM, Steinberg ML. “Health economics and health policy.” Perez & Brady’s Principles and Practice of Radiation Oncology (7th edition). Ed. Halperin EC, Wazer DE, Perez CA, Brady LW. Lippincott Williams & Wilkins. 2018.
Chang E, Goldsby R, Mueller S, Banerjee A. “Late effects and palliative care.” Pediatric CNS Tumors (3rd edition). Ed. Gupta N, Banerjee A, Haas-Kogan D. Springer Science & Business Media. 2016.